PPIA and cancer: We identify an additional set of vulnerabilities/dependencies associated with CYPA loss and inhibition, before showing that pharmacological inhibition of CYPA can selectively kill a diverse set of cancer cell lines with a shared dysregulation of and addiction to HRR.